Charles River Laboratories International

NYSE
CRL
Stock
Yield per half year: -2.17%
Dividend yield: 0%
Sector: Healthcare

Charles River Laboratories International

280.00280.00240.00240.00200.00200.00160.00160.00120.00120.0080.0080.00Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25Jul '25Jul '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
1/10
426.5 52.65 710.13% 113.13 +276.99%
P/S 2.34 4.03 -41.95%
P/BV 2.7 10.86 -75.15%
P/FCF 20.33 39.64 -48.7%
Ev/Ebitda 20.65 16.29 26.74%
Ev/S 2.96 4.35 -31.84%
Ev/FCF 23.92 52.22 -54.19%
E/P 0.0022 0.2095 -98.95%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
4/10
14.35 18.92 -24.17% 19.28 -25.58%
ROE 0.6291 -83.32 -100.76%
ROA 0.2824 6.38 -95.57%
ROIC 9.15 15.07 -39.26%
ROS 0.5482 9.34 -94.13%
ROCE 6.25 84.77 -92.63%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
1/10
4.69 1.04 351.48% 3.79 +23.54%
Nеt Debt/Ebitda 4.35 1.42 206.85%
Debt/Ratio 0.3618 0.2741 32.02%
Debt/Equity 1.15 15.68 -92.69%
Debt/Net Income 122.69 6.8 1704.49%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 1.28 -100% 0 0%
Number of years of dividend growth 0 6.75 -100%
DSI 0 0.7413 -100%
Average dividend growth 0 -4.1 -100%
Average percentage for 5 years 0 1.34 -100%
Average percentage for payments 5.52 44.08 -87.47%
Difference from average difference in sector -1.28

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
5/10
38.51 54.39 -29.2%
Growth impulse Ebitda in 5 years -24.33 -89.73 -72.89%
Growth impulse Net Income in 5 years -93.9 -83.26 12.78%
Growth impulse FCF in 5 years 32 -81.95 -139.05%
Growth impulse EPS in 5 years -94.03 39.71 -336.79%
IP Score
2.92/10

Similar companies

Allergan

UnitedHealth Group

Humana

Bristol-Myers

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription